Cargando…

Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study

BACKGROUND: Antidepressant use is more common in people with Parkinson’s disease (PD), but it is unknown when this difference emerges. METHODS: We studied the incidence of antidepressant use in six-month periods from 10 years before to 15 years after PD diagnosis in the nationwide register-based Fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hentilä, Eerik, Tiihonen, Miia, Taipale, Heidi, Hartikainen, Sirpa, Tolppanen, Anna-Maija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986562/
https://www.ncbi.nlm.nih.gov/pubmed/33757451
http://dx.doi.org/10.1186/s12877-021-02145-6
_version_ 1783668470379970560
author Hentilä, Eerik
Tiihonen, Miia
Taipale, Heidi
Hartikainen, Sirpa
Tolppanen, Anna-Maija
author_facet Hentilä, Eerik
Tiihonen, Miia
Taipale, Heidi
Hartikainen, Sirpa
Tolppanen, Anna-Maija
author_sort Hentilä, Eerik
collection PubMed
description BACKGROUND: Antidepressant use is more common in people with Parkinson’s disease (PD), but it is unknown when this difference emerges. METHODS: We studied the incidence of antidepressant use in six-month periods from 10 years before to 15 years after PD diagnosis in the nationwide register-based Finnish Study on Parkinson’s disease (FINPARK). This study included 20,456 community dwellers with clinically verified PD diagnosed during 1996–2015 and 140,291 matched comparison persons. RESULTS: Altogether 44.3% of people with PD initiated antidepressants, compared to 25.0% of people without PD. The difference was largest 6 months before PD diagnosis (incidence rate ratio 5.28, 95% CI 4.80–5.80; 9.02 and 1.68 initiations/100 person-years in people with and without PD, respectively). The difference emerged already 7 years before the diagnosis and remained above the comparison group for most of the study period. CONCLUSIONS: Persons with PD may have symptoms that require antidepressant treatment years before and after diagnosis. The symptoms needing antidepressant treatment may be clinical signs of possible PD and they should be considered as a need to assess clinical status in person diagnosed with PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-021-02145-6.
format Online
Article
Text
id pubmed-7986562
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79865622021-03-25 Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study Hentilä, Eerik Tiihonen, Miia Taipale, Heidi Hartikainen, Sirpa Tolppanen, Anna-Maija BMC Geriatr Research Article BACKGROUND: Antidepressant use is more common in people with Parkinson’s disease (PD), but it is unknown when this difference emerges. METHODS: We studied the incidence of antidepressant use in six-month periods from 10 years before to 15 years after PD diagnosis in the nationwide register-based Finnish Study on Parkinson’s disease (FINPARK). This study included 20,456 community dwellers with clinically verified PD diagnosed during 1996–2015 and 140,291 matched comparison persons. RESULTS: Altogether 44.3% of people with PD initiated antidepressants, compared to 25.0% of people without PD. The difference was largest 6 months before PD diagnosis (incidence rate ratio 5.28, 95% CI 4.80–5.80; 9.02 and 1.68 initiations/100 person-years in people with and without PD, respectively). The difference emerged already 7 years before the diagnosis and remained above the comparison group for most of the study period. CONCLUSIONS: Persons with PD may have symptoms that require antidepressant treatment years before and after diagnosis. The symptoms needing antidepressant treatment may be clinical signs of possible PD and they should be considered as a need to assess clinical status in person diagnosed with PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-021-02145-6. BioMed Central 2021-03-23 /pmc/articles/PMC7986562/ /pubmed/33757451 http://dx.doi.org/10.1186/s12877-021-02145-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Hentilä, Eerik
Tiihonen, Miia
Taipale, Heidi
Hartikainen, Sirpa
Tolppanen, Anna-Maija
Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
title Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
title_full Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
title_fullStr Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
title_full_unstemmed Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
title_short Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
title_sort incidence of antidepressant use among community dwellers with and without parkinson’s disease – a nationwide cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986562/
https://www.ncbi.nlm.nih.gov/pubmed/33757451
http://dx.doi.org/10.1186/s12877-021-02145-6
work_keys_str_mv AT hentilaeerik incidenceofantidepressantuseamongcommunitydwellerswithandwithoutparkinsonsdiseaseanationwidecohortstudy
AT tiihonenmiia incidenceofantidepressantuseamongcommunitydwellerswithandwithoutparkinsonsdiseaseanationwidecohortstudy
AT taipaleheidi incidenceofantidepressantuseamongcommunitydwellerswithandwithoutparkinsonsdiseaseanationwidecohortstudy
AT hartikainensirpa incidenceofantidepressantuseamongcommunitydwellerswithandwithoutparkinsonsdiseaseanationwidecohortstudy
AT tolppanenannamaija incidenceofantidepressantuseamongcommunitydwellerswithandwithoutparkinsonsdiseaseanationwidecohortstudy